Bei Jing Shang Bao·2025-10-28 13:24Core Viewpoint - Kanglong Chemical plans to invest 1.346 billion yuan to acquire 82.54% of Wuxi Bai'ao Bio-Science Co., Ltd, enhancing its capabilities in drug discovery services [1] Group 1: Acquisition Details - The acquisition amount is 1.346 billion yuan [1] - Kanglong Chemical aims to strengthen its biological science service capabilities through this acquisition [1] Group 2: Company Profile of Bai'ao Bio - Bai'ao Bio focuses on innovative drug research and development, particularly in the drug discovery phase [1] - The company provides scientific research services based on complex drug target protein preparation, with a core emphasis on structural biology and advantages in cryo-electron microscopy [1] Group 3: Strategic Rationale - The structural analysis biology business of Bai'ao Bio is naturally synergistic with Kanglong Chemical's biological science service business [1] - The acquisition is expected to enhance the service capabilities of Kanglong Chemical's biological science business segment, which has seen rapid and steady revenue growth in recent years [1]